Washington, DC - Following a public comment period, the Federal Trade Commission has approved final consent orders involving two auto dealers that deceptively advertised the sale, financing and leasing of their vehicles.

Washington, DC - The Federal Trade Commission today issued an administrative complaint charging that Steris Corporation’s proposed $1.9 billion acquisition of Synergy Health plc would violate the antitrust laws by significantly reducing future competition in regional markets for sterilization of products using radiation, particularly gamma or x-ray radiation.

Washington, DC - The publication, Foreign Affairs, described President Obama as a "progressive pragmatist" when it comes to foreign policy.

Concord, Massachusetts -   On Saturday, June 13, 2015,  the historic Buttrick Garden on the hillside above the North Bridge in Minute Man National Historical Park will provide a beautiful backdrop as the “love letters” of John and Abigail Adams come to life.

Washington, DC - The Federal Trade Commission has reached a settlement resolving the Commission’s antitrust suit charging Cephalon, Inc. with illegally blocking generic competition to its blockbuster sleep-disorder drug Provigil. The settlement ensures that Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total of $1.2 billion available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon’s illegal conduct.

Washington, DC - A Federal Trade Commission report on the pet medications industry noted fast growth and a changing landscape of suppliers – with veterinarians seeing increased competition from non-traditional sellers, and consumers finding more ways to buy medications for their pets. The report made recommendations for ways to make the pet medications market even more competitive.